CN Bio Innovations
Owner/Developer: CN Bio Innovations
CN Bio develops human organ-on-chip technologies: devices that enable the formation of miniature models of human organs in the lab. We provide products and services to the pharmaceutical industry and in the past 3 years have used our proprietary organ-on-chip models in drug discovery and drug safety programs with more than 25 pharmaceutical companies. CN Bio has also pursued research to develop disease organ-on-chip models with successful programmes resulting in novel models of non-alcoholic steatohepatitis and Hepatitis B virus infection.
|Channel:||Website - Social media - Professional online network|
|Audience:||Scientists - Industry - Researchers|
|User access:||Open access|
|Updating frequency:||Frequently updated|
|Relevance:||Replacement - Reduction|
|Purpose:||Toxicological and safety evaluation - Method development - Regulatory testing - Fundamental studies - Efficacy testing|
|Technology/Tools:||Alternative test methods (in vitro) - Tissue engineering|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.